EP1961418A4 - Utilisation de composes a base d'isothiocyanates dans le traitement de maladies prostatiques et du cancer de la peau - Google Patents

Utilisation de composes a base d'isothiocyanates dans le traitement de maladies prostatiques et du cancer de la peau

Info

Publication number: EP1961418A4
Authority: EP; European Patent Office
Prior art keywords: treatment; isothiocyanate; based compounds; skin cancer; prostatic diseases
Prior art date: 2005-11-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP06817815A

Other languages

German (de)

English (en)

Other versions

EP1961418B1 (fr

EP1961418A1 (fr

Inventor

Jenwei Chiao

Haiya Jin

Chengjuan Zhong

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-15

Filing date

2006-11-14

Publication date

2009-09-02

2005-11-15 Priority claimed from CN 200510095737 external-priority patent/CN1769268A/zh

2006-01-27 Priority claimed from CNA2006100381121A external-priority patent/CN1840196A/zh

2006-11-14 Application filed by Individual filed Critical Individual

2006-11-14 Priority to DK11186579.6T priority Critical patent/DK2441454T3/en

2006-11-14 Priority to EP11186579.6A priority patent/EP2441454B1/fr

2008-08-27 Publication of EP1961418A1 publication Critical patent/EP1961418A1/fr

2009-09-02 Publication of EP1961418A4 publication Critical patent/EP1961418A4/fr

2012-04-04 Application granted granted Critical

2012-04-04 Publication of EP1961418B1 publication Critical patent/EP1961418B1/fr

Status Active legal-status Critical Current

2026-11-14 Anticipated expiration legal-status Critical

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

EP06817815A 2005-11-15 2006-11-14 Utilisation de composes a base d'isothiocyanates dans le traitement de maladies prostatiques et du cancer de la peau Active EP1961418B1 (fr)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
DK11186579.6T DK2441454T3 (en)	2005-11-15	2006-11-14	Use of isothiocyanatforbindelser for the treatment of prostatitis
EP11186579.6A EP2441454B1 (fr)	2005-11-15	2006-11-14	Utilisation de composés isothiocyanates pour le traitement de la prostatite

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CN 200510095737 CN1769268A (zh)	2005-11-15	2005-11-15	一种天然及人工合成的异硫氰酸酯类化合物jc－5411在制备转录因子sp1的抑制剂中的应用
CNA2006100381121A CN1840196A (zh)	2006-01-27	2006-01-27	一种适用于难溶性药物的分散剂
PCT/CN2006/003062 WO2007056941A1 (fr)	2005-11-15	2006-11-14	Utilisation de composes a base d'isothiocyanates dans le traitement de maladies prostatiques et du cancer de la peau

Related Child Applications (2)

Application Number	Title	Priority Date	Filing Date
EP11186579.6A Division EP2441454B1 (fr)	2005-11-15	2006-11-14	Utilisation de composés isothiocyanates pour le traitement de la prostatite
EP11186579.6 Division-Into		2011-10-25

Publications (3)

Publication Number	Publication Date
EP1961418A1 EP1961418A1 (fr)	2008-08-27
EP1961418A4 true EP1961418A4 (fr)	2009-09-02
EP1961418B1 EP1961418B1 (fr)	2012-04-04

Family

ID=38048290

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
EP06817815A Active EP1961418B1 (fr)	2005-11-15	2006-11-14	Utilisation de composes a base d'isothiocyanates dans le traitement de maladies prostatiques et du cancer de la peau
EP11186579.6A Active EP2441454B1 (fr)	2005-11-15	2006-11-14	Utilisation de composés isothiocyanates pour le traitement de la prostatite

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
EP11186579.6A Active EP2441454B1 (fr)	2005-11-15	2006-11-14	Utilisation de composés isothiocyanates pour le traitement de la prostatite

Country Status (7)

Country	Link
US (2)	US8039511B2 (fr)
EP (2)	EP1961418B1 (fr)
JP (1)	JP5308160B2 (fr)
AT (1)	ATE552000T1 (fr)
CA (1)	CA2630262C (fr)
DK (2)	DK1961418T3 (fr)
WO (1)	WO2007056941A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8665785B2 (en) *	2009-09-11	2014-03-04	Enversa Companies, Llc	Systems and methods for establishing a telecommunications bridge between a user device and a node
CN102160872A (zh)	2010-02-23	2011-08-24	天津天士力制药股份有限公司	复方丹参滴丸胶囊
US8414869B2 (en) *	2010-11-30	2013-04-09	N.V. Perricone Llc	Melanin promoting topical composition
US10647668B2 (en)	2011-01-03	2020-05-12	The William M. Yarbrough Foundation	Isothiocyanate functional surfactant and associated method of use
US8933119B2 (en)	2011-01-03	2015-01-13	The William M. Yarbrough Foundation	Method for treating phytophotodermatitis
US10308599B2 (en)	2011-01-03	2019-06-04	The William M. Yarbrough Foundation	Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US11407713B2 (en)	2011-01-03	2022-08-09	The William M. Yarbrough Foundation	Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10273205B2 (en)	2011-01-03	2019-04-30	The William M. Yarbrough Foundation	Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US9962361B2 (en)	2011-01-03	2018-05-08	The William M. Yarbrough Foundation	Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US11279674B2 (en)	2011-01-03	2022-03-22	The William M. Yarbrough Foundation	Isothiocyanate functional surfactant and associated method of use
US10640464B2 (en)	2011-01-03	2020-05-05	The William M. Yarbrough Foundation	Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US8865765B2 (en) *	2011-01-12	2014-10-21	The William M. Yarbrough Foundation	Method for treating eczema
US9532969B2 (en)	2011-02-08	2017-01-03	The William M. Yarbrough Foundation	Method for treating psoriasis
WO2014018874A1 (fr)	2012-07-26	2014-01-30	The William M. Yarbrough Foundation	Méthode de traitement du cancer de la peau
US10335387B2 (en)	2012-07-26	2019-07-02	The William M. Yarbrough Foundation	Method for treating infectious diseases with isothiocyanate functional compounds
US10080734B2 (en)	2012-07-26	2018-09-25	The William M. Yarbrough Foundation	Method for treating autism and other neurodevelopmental disorders
US9949943B2 (en)	2012-07-26	2018-04-24	The William M. Yarbrough Foundation	Method for treating neurodegenerative diseases
US10441561B2 (en)	2012-07-26	2019-10-15	The William M. Yanbrough Foundation	Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10434081B2 (en)	2012-07-26	2019-10-08	The William M. Yarbrough Foundation	Inhibitors of macrophage migration inhibitory factor
US10434082B2 (en)	2012-07-26	2019-10-08	The William M. Yarbrough Foundation	Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US9839621B2 (en)	2012-07-26	2017-12-12	The William M. Yarbrough Foundation	Method for treating bladder cancer
TWI495464B (zh) *	2013-02-08	2015-08-11	Univ Nat Taiwan	苦味化合物於活化ｇｌｐ－１分泌之用途
EP3034076B1 (fr) *	2013-08-13	2020-09-30	JC (Wuxi) COMPANY, Inc.	Utilisation combinée d'un médicament anti-cancéreux et d'un composé de la classe des isothiocyanates
US20160361380A1 (en) *	2015-06-12	2016-12-15	Nymox Corporation	Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
EA202090732A1 (ru) *	2017-09-15	2020-07-29	Тайм, Инк.	Составы для трансдермального введения
DE102018121251A1 (de) *	2018-08-30	2020-03-05	Shenstone Consultants Ltd.	Isothiocyanate
WO2020232227A1 (fr)	2019-05-14	2020-11-19	Tyme, Inc.	Compositions et méthodes de traitement du cancer
MX2022000419A (es)	2019-07-10	2022-02-10	Nanometics Llc D B A Phd Biosciences	Geles de poliuretano.
MX2022002450A (es)	2019-08-30	2022-03-22	Grant Ind Inc	Elastomero de base biologica y biodegradable para el cuidado cosmetico y personal.
IT201900025840A1 (it) *	2019-12-31	2021-07-01	Univ Bologna Alma Mater Studiorum	Composti isotiocianati e isoselencianati
US10905698B1 (en)	2020-05-14	2021-02-02	Tyme, Inc.	Methods of treating SARS-COV-2 infections

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050070602A1 (en) *	2003-09-30	2005-03-31	Jen-Wei Chiao	Method of modulating immune response by administration of immuno-activation agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060069151A1 (en) *	2002-12-06	2006-03-30	Luca Barella	Novel use of lycopene
CN100448845C (zh)	2005-06-30	2009-01-07	无锡杰西医药科技有限公司	一种天然及人工合成的异硫氰酸酯类化合物jc－5411在制备预防和治疗前列腺癌、肝癌、胃癌、肺癌、乳腺癌、宫颈癌、黑色素瘤和神经母细胞瘤的药物中的应用
WO2008046140A1 (fr) *	2006-10-17	2008-04-24	Summa Development Limited	Traitement amélioré d'une hyperplasie bénigne de la prostate

2006
- 2006-11-14 AT AT06817815T patent/ATE552000T1/de active
- 2006-11-14 EP EP06817815A patent/EP1961418B1/fr active Active
- 2006-11-14 DK DK06817815.1T patent/DK1961418T3/da active
- 2006-11-14 JP JP2008540431A patent/JP5308160B2/ja active Active
- 2006-11-14 US US12/093,829 patent/US8039511B2/en active Active
- 2006-11-14 CA CA2630262A patent/CA2630262C/fr active Active
- 2006-11-14 WO PCT/CN2006/003062 patent/WO2007056941A1/fr not_active Ceased
- 2006-11-14 EP EP11186579.6A patent/EP2441454B1/fr active Active
- 2006-11-14 DK DK11186579.6T patent/DK2441454T3/en active
2011
- 2011-09-13 US US13/231,406 patent/US8410170B2/en not_active Expired - Fee Related

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050070602A1 (en) *	2003-09-30	2005-03-31	Jen-Wei Chiao	Method of modulating immune response by administration of immuno-activation agent

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEN Y-R ET AL: "Phenylethyl isothiocyanate induces apoptotic signaling via suppressing phosphatase activity against c-Jun N-terminal kinase", JOURNAL OF BIOLOGICAL CHEMISTRY 20021018 AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY INC. US, vol. 277, no. 42, 18 October 2002 (2002-10-18), pages 39334 - 39342, XP002536843 *
MYZAK MELINDA C ET AL: "Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells", CARCINOGENESIS (OXFORD), vol. 27, no. 4, April 2006 (2006-04-01), pages 811 - 819, XP002536845, ISSN: 0143-3334 *
SRIVASTAVA SANJAY K ET AL: "Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.", CARCINOGENESIS (OXFORD), vol. 24, no. 10, October 2003 (2003-10-01), pages 1665 - 1670, XP002536844, ISSN: 0143-3334 *
WANG L G ET AL: "Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate", CARCINOGENESIS (OXFORD), vol. 27, no. 10, October 2006 (2006-10-01), pages 2124 - 2132, XP002536846, ISSN: 0143-3334 *
ZUNIGA ZACHARY V ET AL: "Isothiocyanates inhibit cell growth and induce apoptosis in prostate cancer cells derived from TRAMP mice", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, vol. 43, March 2002 (2002-03-01), & 93RD ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH; SAN FRANCISCO, CALIFORNIA, USA; APRIL 06-10, 2002, pages 640, XP001539400, ISSN: 0197-016X *

Also Published As

Publication number	Publication date
EP2441454B1 (fr)	2015-09-16
WO2007056941A1 (fr)	2007-05-24
DK1961418T3 (da)	2012-07-23
ATE552000T1 (de)	2012-04-15
US20090005438A1 (en)	2009-01-01
US8410170B2 (en)	2013-04-02
JP2009515910A (ja)	2009-04-16
EP1961418B1 (fr)	2012-04-04
JP5308160B2 (ja)	2013-10-09
CA2630262C (fr)	2011-11-08
US20120046358A1 (en)	2012-02-23
CA2630262A1 (fr)	2007-05-24
DK2441454T3 (en)	2015-12-21
EP1961418A1 (fr)	2008-08-27
US8039511B2 (en)	2011-10-18
EP2441454A1 (fr)	2012-04-18

Legal Events

Date	Code	Title	Description
2008-07-25	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2008-08-27	17P	Request for examination filed	Effective date: 20080613
2008-08-27	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2009-09-02	A4	Supplementary search report drawn up and despatched	Effective date: 20090731
2009-11-18	17Q	First examination report despatched	Effective date: 20091015
2011-09-09	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2011-10-12	DAX	Request for extension of the european patent (deleted)
2012-01-31	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2012-02-15	RIN1	Information on inventor provided before grant (corrected)	Inventor name: CHIAO, JENWEI Inventor name: CHENG, JINGCAI Inventor name: JIN, HAIYA Inventor name: ZHONG, CHENGJUAN
2012-02-29	RIN1	Information on inventor provided before grant (corrected)	Inventor name: ZHONG, CHENGJUAN Inventor name: JIN, HAIYA Inventor name: CHENG, JINCAI Inventor name: CHIAO, JENWEI
2012-03-02	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2012-04-04	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2012-04-04	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2012-04-13	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2012-04-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: REF Ref document number: 552000 Country of ref document: AT Kind code of ref document: T Effective date: 20120415
2012-04-25	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2012-05-31	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602006028660 Country of ref document: DE Effective date: 20120531
2012-06-29	REG	Reference to a national code	Ref country code: CH Ref legal event code: NV Representative=s name: MARK-PAT MODIANO S.A.
2012-07-11	REG	Reference to a national code	Ref country code: NL Ref legal event code: T3
2012-07-23	REG	Reference to a national code	Ref country code: DK Ref legal event code: T3
2012-08-07	REG	Reference to a national code	Ref country code: SE Ref legal event code: TRGR
2012-09-25	LTIE	Lt: invalidation of european patent or patent extension	Effective date: 20120404
2012-10-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120404 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120404 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120404 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120404 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120404 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120804
2012-10-31	REG	Reference to a national code	Ref country code: NL Ref legal event code: T3
2012-11-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120705 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120806 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120404
2013-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120404 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120404 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120404 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120404
2013-02-08	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2013-02-08	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2013-03-13	26N	No opposition filed	Effective date: 20130107
2013-04-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120715
2013-05-02	REG	Reference to a national code	Ref country code: DE Ref legal event code: R097 Ref document number: 602006028660 Country of ref document: DE Effective date: 20130107
2013-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120704
2014-04-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121130 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120404
2014-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20061114
2015-01-28	REG	Reference to a national code	Ref country code: DE Ref legal event code: R082 Ref document number: 602006028660 Country of ref document: DE Representative=s name: SCHIEBER - FARAGO, DE
2015-01-30	REG	Reference to a national code	Ref country code: CH Ref legal event code: PUE Owner name: JC (WUXI) COMPANY, INC., CN Free format text: FORMER OWNER: CHENG, JINGCAI, CN Ref country code: CH Ref legal event code: NV Representative=s name: MODIANO AND PARTNERS SA, CH
2015-02-18	REG	Reference to a national code	Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20150122 AND 20150128
2015-03-05	REG	Reference to a national code	Ref country code: DE Ref legal event code: R081 Ref document number: 602006028660 Country of ref document: DE Owner name: JC (WUXI) COMPANY, INC., CN Free format text: FORMER OWNER: CHENG, JINGCAI, WUXI, JIANGSU, CN Effective date: 20150128 Ref country code: DE Ref legal event code: R082 Ref document number: 602006028660 Country of ref document: DE Representative=s name: SCHIEBER - FARAGO, DE Effective date: 20150128 Ref country code: DE Ref legal event code: R082 Ref document number: 602006028660 Country of ref document: DE Representative=s name: FARAGO PATENTANWAELTE, DE Effective date: 20150128 Ref country code: DE Ref legal event code: R082 Ref document number: 602006028660 Country of ref document: DE Representative=s name: FARAGO PATENTANWALTS- UND RECHTSANWALTSGESELLS, DE Effective date: 20150128
2015-03-13	REG	Reference to a national code	Ref country code: FR Ref legal event code: TP Owner name: JC COMPANY, INC., CN Effective date: 20150212
2015-04-01	REG	Reference to a national code	Ref country code: NL Ref legal event code: SD Effective date: 20150327
2015-11-10	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10
2016-05-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: PC Ref document number: 552000 Country of ref document: AT Kind code of ref document: T Owner name: JC (WUXI) COMPANY, INC., CN Effective date: 20160321
2016-10-14	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11
2017-10-26	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12
2018-07-13	REG	Reference to a national code	Ref country code: CH Ref legal event code: PCAR Free format text: NEW ADDRESS: VIA E. BOSSI 1, 6900 LUGANO (CH)
2018-10-26	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13
2022-07-21	REG	Reference to a national code	Ref country code: DE Ref legal event code: R082 Ref document number: 602006028660 Country of ref document: DE Representative=s name: SCHIEBER - FARAGO PATENTANWAELTE, DE Ref country code: DE Ref legal event code: R082 Ref document number: 602006028660 Country of ref document: DE Representative=s name: FARAGO PATENTANWALTSGESELLSCHAFT MBH, DE
2022-09-08	REG	Reference to a national code	Ref country code: DE Ref legal event code: R082 Ref document number: 602006028660 Country of ref document: DE Representative=s name: SCHIEBER - FARAGO PATENTANWAELTE, DE
2023-01-31	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: SE Payment date: 20221110 Year of fee payment: 17 Ref country code: NL Payment date: 20221114 Year of fee payment: 17 Ref country code: LU Payment date: 20221114 Year of fee payment: 17 Ref country code: IT Payment date: 20221111 Year of fee payment: 17 Ref country code: IE Payment date: 20221109 Year of fee payment: 17 Ref country code: GB Payment date: 20221110 Year of fee payment: 17 Ref country code: FR Payment date: 20221110 Year of fee payment: 17 Ref country code: DK Payment date: 20221111 Year of fee payment: 17 Ref country code: DE Payment date: 20221108 Year of fee payment: 17 Ref country code: AT Payment date: 20221109 Year of fee payment: 17
2023-02-28	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: CH Payment date: 20221129 Year of fee payment: 17 Ref country code: BE Payment date: 20221118 Year of fee payment: 17
2023-07-12	P01	Opt-out of the competence of the unified patent court (upc) registered	Effective date: 20230527
2024-06-01	REG	Reference to a national code	Ref country code: DE Ref legal event code: R119 Ref document number: 602006028660 Country of ref document: DE
2024-06-24	REG	Reference to a national code	Ref country code: DK Ref legal event code: EBP Effective date: 20231130
2024-06-28	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2024-07-02	REG	Reference to a national code	Ref country code: SE Ref legal event code: EUG
2024-07-03	REG	Reference to a national code	Ref country code: NL Ref legal event code: MM Effective date: 20231201
2024-07-15	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231114
2024-07-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: MM01 Ref document number: 552000 Country of ref document: AT Kind code of ref document: T Effective date: 20231114
2024-07-18	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130
2024-07-23	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231114
2024-07-24	GBPC	Gb: european patent ceased through non-payment of renewal fee	Effective date: 20231114
2024-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231114 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231114
2024-08-01	REG	Reference to a national code	Ref country code: BE Ref legal event code: MM Effective date: 20231130
2024-08-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231115
2024-09-03	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231201
2024-09-11	REG	Reference to a national code	Ref country code: IE Ref legal event code: MM4A
2024-09-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231201
2024-10-10	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231114 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240601
2024-10-11	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130
2024-10-14	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231114
2024-10-15	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130
2024-10-16	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130
2024-10-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231114 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231114 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240601 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130
2024-12-03	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231114
2024-12-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231114

Publication	Publication Date	Title
EP1961418A4 (fr)	2009-09-02	Utilisation de composes a base d'isothiocyanates dans le traitement de maladies prostatiques et du cancer de la peau
HUS1500048I1 (hu)	2017-10-30	Ivermectin helyi kiszerelése dermatológiai állapotok kezelésére
CY2015025I1 (el)	2016-04-13	Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
ME01222B (me)	2013-06-20	Nova kombinovana upotreba jedinjenja sulfonamida u liječenju kancera
EP1969937A3 (fr)	2013-01-02	Agent pour le traitement des semences de soja
NL1026892A1 (nl)	2005-02-28	ó1,8!Naftyridin-2-onen en verwante verbindingen voor de behandeling van schizofrenie.
BRPI0506305A (pt)	2006-09-19	artigos e métodos de tratamento da pele
DE60325209D1 (de)	2009-01-22	Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen
ES2414872T8 (es)	2014-11-06	Terapia combinada para la prevención o tratamiento de la enfermedad de Alzheimer y kit correspondiente
ATE535236T1 (de)	2011-12-15	Therapeutische strategien für die prävention und behandlung der alzheimer-krankheit
DE60304102D1 (de)	2006-05-11	Hautreinigungszusammensetzung
EP1928398A4 (fr)	2014-10-01	Composition cosmetique contenant des microspheres thermoplastiques et des agents benefiques pour la peau
DE60318839D1 (de)	2008-03-13	2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
ATE516037T1 (de)	2011-07-15	Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
CY1110061T1 (el)	2015-01-14	Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
PL1708991T3 (pl)	2008-02-29	Pochodne sulfonoamidu do leczenia chorób
ATE401875T1 (de)	2008-08-15	Pharmazeutische feste dispersionen von modafinil- verbindungen
NO20071798L (no)	2007-04-03	Dermalt pafore formuleringer for behandling av hudsykdommer i dyr
DE60223576D1 (de)	2007-12-27	Hautbehandlungszusammensetzung
FR2834459B1 (fr)	2006-08-04	Agent microbicide et composition de traitement cosmetique le contenant
FR2846239B1 (fr)	2006-08-04	Composition de cosmetique destinee a blanchir la peau comprenant du senkyunolide a en tant que principe actif
DE60334632D1 (de)	2010-12-02	Mechanolumineszenzstoff und dessen herstellung
DE60222664D1 (de)	2007-11-08	Hautbehandlungsmittel
FR2845267B1 (fr)	2004-12-31	Kit cutane de diagnostic de l'atopie
PL355298A1 (pl)	2004-02-09	Preparat dermatologiczny do leczenia uszkodzesigma skóry